PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.22%
Positive revenue growth while CSIQ is negative. John Neff might see a notable competitive edge here.
401.45%
Positive gross profit growth while CSIQ is negative. John Neff would see a clear operational edge over the competitor.
9.96%
Positive EBIT growth while CSIQ is negative. John Neff might see a substantial edge in operational management.
3.07%
Positive operating income growth while CSIQ is negative. John Neff might view this as a competitive edge in operations.
19.72%
Positive net income growth while CSIQ is negative. John Neff might see a big relative performance advantage.
-40.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-37.93%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.07%
Share change of 0.07% while CSIQ is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-0.05%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-68.96%
Negative OCF growth while CSIQ is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-175.51%
Negative FCF growth while CSIQ is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
6103.75%
10Y revenue/share CAGR above 1.5x CSIQ's 2127.31%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
6103.75%
5Y revenue/share CAGR above 1.5x CSIQ's 2127.31%. David Dodd would look for consistent product or market expansions fueling outperformance.
295.54%
3Y revenue/share CAGR under 50% of CSIQ's 1077.22%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
2525.30%
OCF/share CAGR of 2525.30% while CSIQ is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
2525.30%
OCF/share CAGR of 2525.30% while CSIQ is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
15668.27%
3Y OCF/share CAGR of 15668.27% while CSIQ is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
358.17%
Positive 10Y CAGR while CSIQ is negative. John Neff might see a substantial advantage in bottom-line trajectory.
358.17%
Positive 5Y CAGR while CSIQ is negative. John Neff might view this as a strong mid-term relative advantage.
1436.34%
Positive short-term CAGR while CSIQ is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.29%
Below 50% of CSIQ's 3635.72%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.87%
Our AR growth while CSIQ is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
31.97%
We show growth while CSIQ is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
7.73%
Positive asset growth while CSIQ is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.37%
Positive BV/share change while CSIQ is negative. John Neff sees a clear edge over a competitor losing equity.
12.52%
We have some new debt while CSIQ reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-126.33%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-6.18%
We cut SG&A while CSIQ invests at 18.45%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.